Algal Bio
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
$460k | Early VC | ||
$3.7m | Series A | ||
N/A | Support Program | ||
$6.7m | Series B | ||
Total Funding | $10.9m |
Related Content
Recent News about Algal Bio
EditAlgal Bio Co., Ltd. is a pioneering biotech company specializing in algae-based technologies to create sustainable and clean solutions. The company operates in the biotechnology sector, focusing on the development and commercialization of algae-derived products. Algal Bio collaborates with leading universities and research institutions, including The University of Tokyo, to enhance its technological capabilities and drive innovation. The company serves a diverse range of clients, including those in the food, biofuel, and alternative protein industries. By leveraging the untapped potential of various algae species, Algal Bio aims to provide high-protein alternatives and raw materials for biofuels, contributing to a more sustainable future. The business model is centered around research and development, partnerships, and commercialization of algae-based products. Revenue is generated through the sale of these innovative products and through strategic collaborations.
Keywords: algae-based biotech, sustainable solutions, clean technology, alternative proteins, biofuels, research collaborations, innovation, biotechnology, commercialization, high-protein alternatives.